FDA NDC Directory · JSON-LD · Markdown

Ganirelix Acetate

NDC 0548-5001 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerAmphastar Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212613
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsGANIRELIX ACETATE (250 ug/.5mL)
Marketing started20220620
Package count1

External sources

Source: openFDA. Public-domain (CC0).